SARAH BURT: Open Payments
NPI 1689067506 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 44 payments from 6 companies in 2025. Trend: 2023 $866 · 2024 $608 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $346 |
| Otsuka America Pharmaceutical, Inc. | 4 | $238 |
| Vanda Pharmaceuticals Inc. | 5 | $120 |
| Alkermes, Inc. | 3 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, FANAPT, ABILIFY MAINTENA, REXULTI, ARISTADA, INGREZZA, ABILIFY ASIMTUFII, LYBALVI.
Industry payments across WY — which companies pay providers there.
